New lifesaving drugs too expensive for most drug-resistant TB patients: MSF

LONDON (Thomson Reuters Foundation) - Only 2 percent of people with the most severe cases of drug-resistant tuberculosis (TB) have access to the latest life-saving drugs because of their high price, the medical charity Medecins Sans Frontieres (MSF) said on Monday.